Heparin-responsive angiopathy in the central nervous system caused by intravascular large B-cell lymphoma

[1]  L. Borsig,et al.  The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. , 2014, Thrombosis research.

[2]  Kazuya Sato,et al.  Prognostic impact of extranodal involvement in diffuse large B‐cell lymphoma in the rituximab era , 2012, Cancer.

[3]  R. Zeisig,et al.  The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives. , 2012, Thrombosis research.

[4]  L. Borsig,et al.  Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins , 2012, International journal of cell biology.

[5]  A. Khorana,et al.  A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment , 2007, Cancer.

[6]  D. Rontogianni,et al.  Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy. , 2006, The oncologist.

[7]  J. Berger,et al.  Intravascular lymphomatosis presenting with sudden hearing loss , 2005, Journal of the Neurological Sciences.

[8]  A. López-Guillermo,et al.  Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’ 1 , 2004, British journal of haematology.

[9]  A. Patchefsky,et al.  Case report 3 , 1976, Skeletal Radiology.

[10]  T. Yoshino,et al.  Intravascular lymphomatosis of the skin as a manifestation of recurrent B-cell lymphoma. , 2003, Journal of the American Academy of Dermatology.

[11]  K. Ohshima,et al.  Intravascular large cell lymphoma: clinicopathological, immuno-histochemical and molecular genetic studies. , 1999, Leukemia & lymphoma.